Rheonix Plans FDA Submission for Warfarin Sensitivity Test

The firm intends to file for FDA clearance of the test, which would run on its CARD molecular diagnostics system.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.